Priapism: Pathogenesis, epidemiology, and management

Gregory A. Broderick, Ates Kadioglu, Trinity Bivalacqua, Hussein Ghanem, Ajay Nehra, Rany Shamloul

Research output: Contribution to journalArticle

Abstract

Introduction: Priapism describes a persistent erection arising from dysfunction of mechanisms regulating penile tumescence, rigidity, and flaccidity. A correct diagnosis of priapism is a matter of urgency requiring identification of underlying hemodynamics. Aims: To define the types of priapism, address its pathogenesis and epidemiology, and develop an evidence-based guideline for effective management. Methods: Six experts from four countries developed a consensus document on priapism; this document was presented for peer review and debate in a public forum and revisions were made based on recommendations of chairpersons to the International Consultation on Sexual Medicine. This report focuses on guidelines written over the past decade and reviews the priapism literature from 2003 to 2009. Although the literature is predominantly case series, recent reports have more detailed methodology including duration of priapism, etiology of priapism, and erectile function outcomes. Main Outcome Measures: Consensus recommendations were based on evidence-based literature, best medical practices, and bench research. Results: Basic science supporting current concepts in the pathophysiology of priapism, and clinical research supporting the most effective treatment strategies are summarized in this review. Conclusions: Prompt diagnosis and appropriate management of priapism are necessary to spare patients ineffective interventions and maximize erectile function outcomes. Future research is needed to understand corporal smooth muscle pathology associated with genetic and acquired conditions resulting in ischemic priapism. Better understanding of molecular mechanisms involved in the pathogenesis of stuttering ischemic priapism will offer new avenues for medical intervention. Documenting erectile function outcomes based on duration of ischemic priapism, time to interventions, and types of interventions is needed to establish evidence-based guidance. In contrast, pathogenesis of nonischemic priapism is understood, and largely attributable to trauma. Better documentation of onset of high-flow priapism in relation to time of injury, and response to conservative management vs. angiogroaphic or surgical interventions is needed to establish evidence-based guidance.

Original languageEnglish (US)
Pages (from-to)476-500
Number of pages25
JournalJournal of Sexual Medicine
Volume7
Issue number1 PART 2
DOIs
StatePublished - Jan 2010

Fingerprint

Priapism
Epidemiology
Consensus
Guidelines
Penile Erection
Stuttering
Peer Review
Wounds and Injuries
Practice Guidelines
Research
Developed Countries
Documentation

Keywords

  • Ischemic priapism
  • Nonischemic priapism
  • Penile embolization
  • Penile shunt
  • Priapism
  • Prolonged erection
  • Sickle-cell priapism
  • Stuttering priapism

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Broderick, G. A., Kadioglu, A., Bivalacqua, T., Ghanem, H., Nehra, A., & Shamloul, R. (2010). Priapism: Pathogenesis, epidemiology, and management. Journal of Sexual Medicine, 7(1 PART 2), 476-500. https://doi.org/10.1111/j.1743-6109.2009.01625.x

Priapism : Pathogenesis, epidemiology, and management. / Broderick, Gregory A.; Kadioglu, Ates; Bivalacqua, Trinity; Ghanem, Hussein; Nehra, Ajay; Shamloul, Rany.

In: Journal of Sexual Medicine, Vol. 7, No. 1 PART 2, 01.2010, p. 476-500.

Research output: Contribution to journalArticle

Broderick, GA, Kadioglu, A, Bivalacqua, T, Ghanem, H, Nehra, A & Shamloul, R 2010, 'Priapism: Pathogenesis, epidemiology, and management', Journal of Sexual Medicine, vol. 7, no. 1 PART 2, pp. 476-500. https://doi.org/10.1111/j.1743-6109.2009.01625.x
Broderick, Gregory A. ; Kadioglu, Ates ; Bivalacqua, Trinity ; Ghanem, Hussein ; Nehra, Ajay ; Shamloul, Rany. / Priapism : Pathogenesis, epidemiology, and management. In: Journal of Sexual Medicine. 2010 ; Vol. 7, No. 1 PART 2. pp. 476-500.
@article{9890c6e21d8848f291b994cfe6d74450,
title = "Priapism: Pathogenesis, epidemiology, and management",
abstract = "Introduction: Priapism describes a persistent erection arising from dysfunction of mechanisms regulating penile tumescence, rigidity, and flaccidity. A correct diagnosis of priapism is a matter of urgency requiring identification of underlying hemodynamics. Aims: To define the types of priapism, address its pathogenesis and epidemiology, and develop an evidence-based guideline for effective management. Methods: Six experts from four countries developed a consensus document on priapism; this document was presented for peer review and debate in a public forum and revisions were made based on recommendations of chairpersons to the International Consultation on Sexual Medicine. This report focuses on guidelines written over the past decade and reviews the priapism literature from 2003 to 2009. Although the literature is predominantly case series, recent reports have more detailed methodology including duration of priapism, etiology of priapism, and erectile function outcomes. Main Outcome Measures: Consensus recommendations were based on evidence-based literature, best medical practices, and bench research. Results: Basic science supporting current concepts in the pathophysiology of priapism, and clinical research supporting the most effective treatment strategies are summarized in this review. Conclusions: Prompt diagnosis and appropriate management of priapism are necessary to spare patients ineffective interventions and maximize erectile function outcomes. Future research is needed to understand corporal smooth muscle pathology associated with genetic and acquired conditions resulting in ischemic priapism. Better understanding of molecular mechanisms involved in the pathogenesis of stuttering ischemic priapism will offer new avenues for medical intervention. Documenting erectile function outcomes based on duration of ischemic priapism, time to interventions, and types of interventions is needed to establish evidence-based guidance. In contrast, pathogenesis of nonischemic priapism is understood, and largely attributable to trauma. Better documentation of onset of high-flow priapism in relation to time of injury, and response to conservative management vs. angiogroaphic or surgical interventions is needed to establish evidence-based guidance.",
keywords = "Ischemic priapism, Nonischemic priapism, Penile embolization, Penile shunt, Priapism, Prolonged erection, Sickle-cell priapism, Stuttering priapism",
author = "Broderick, {Gregory A.} and Ates Kadioglu and Trinity Bivalacqua and Hussein Ghanem and Ajay Nehra and Rany Shamloul",
year = "2010",
month = "1",
doi = "10.1111/j.1743-6109.2009.01625.x",
language = "English (US)",
volume = "7",
pages = "476--500",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "1 PART 2",

}

TY - JOUR

T1 - Priapism

T2 - Pathogenesis, epidemiology, and management

AU - Broderick, Gregory A.

AU - Kadioglu, Ates

AU - Bivalacqua, Trinity

AU - Ghanem, Hussein

AU - Nehra, Ajay

AU - Shamloul, Rany

PY - 2010/1

Y1 - 2010/1

N2 - Introduction: Priapism describes a persistent erection arising from dysfunction of mechanisms regulating penile tumescence, rigidity, and flaccidity. A correct diagnosis of priapism is a matter of urgency requiring identification of underlying hemodynamics. Aims: To define the types of priapism, address its pathogenesis and epidemiology, and develop an evidence-based guideline for effective management. Methods: Six experts from four countries developed a consensus document on priapism; this document was presented for peer review and debate in a public forum and revisions were made based on recommendations of chairpersons to the International Consultation on Sexual Medicine. This report focuses on guidelines written over the past decade and reviews the priapism literature from 2003 to 2009. Although the literature is predominantly case series, recent reports have more detailed methodology including duration of priapism, etiology of priapism, and erectile function outcomes. Main Outcome Measures: Consensus recommendations were based on evidence-based literature, best medical practices, and bench research. Results: Basic science supporting current concepts in the pathophysiology of priapism, and clinical research supporting the most effective treatment strategies are summarized in this review. Conclusions: Prompt diagnosis and appropriate management of priapism are necessary to spare patients ineffective interventions and maximize erectile function outcomes. Future research is needed to understand corporal smooth muscle pathology associated with genetic and acquired conditions resulting in ischemic priapism. Better understanding of molecular mechanisms involved in the pathogenesis of stuttering ischemic priapism will offer new avenues for medical intervention. Documenting erectile function outcomes based on duration of ischemic priapism, time to interventions, and types of interventions is needed to establish evidence-based guidance. In contrast, pathogenesis of nonischemic priapism is understood, and largely attributable to trauma. Better documentation of onset of high-flow priapism in relation to time of injury, and response to conservative management vs. angiogroaphic or surgical interventions is needed to establish evidence-based guidance.

AB - Introduction: Priapism describes a persistent erection arising from dysfunction of mechanisms regulating penile tumescence, rigidity, and flaccidity. A correct diagnosis of priapism is a matter of urgency requiring identification of underlying hemodynamics. Aims: To define the types of priapism, address its pathogenesis and epidemiology, and develop an evidence-based guideline for effective management. Methods: Six experts from four countries developed a consensus document on priapism; this document was presented for peer review and debate in a public forum and revisions were made based on recommendations of chairpersons to the International Consultation on Sexual Medicine. This report focuses on guidelines written over the past decade and reviews the priapism literature from 2003 to 2009. Although the literature is predominantly case series, recent reports have more detailed methodology including duration of priapism, etiology of priapism, and erectile function outcomes. Main Outcome Measures: Consensus recommendations were based on evidence-based literature, best medical practices, and bench research. Results: Basic science supporting current concepts in the pathophysiology of priapism, and clinical research supporting the most effective treatment strategies are summarized in this review. Conclusions: Prompt diagnosis and appropriate management of priapism are necessary to spare patients ineffective interventions and maximize erectile function outcomes. Future research is needed to understand corporal smooth muscle pathology associated with genetic and acquired conditions resulting in ischemic priapism. Better understanding of molecular mechanisms involved in the pathogenesis of stuttering ischemic priapism will offer new avenues for medical intervention. Documenting erectile function outcomes based on duration of ischemic priapism, time to interventions, and types of interventions is needed to establish evidence-based guidance. In contrast, pathogenesis of nonischemic priapism is understood, and largely attributable to trauma. Better documentation of onset of high-flow priapism in relation to time of injury, and response to conservative management vs. angiogroaphic or surgical interventions is needed to establish evidence-based guidance.

KW - Ischemic priapism

KW - Nonischemic priapism

KW - Penile embolization

KW - Penile shunt

KW - Priapism

KW - Prolonged erection

KW - Sickle-cell priapism

KW - Stuttering priapism

UR - http://www.scopus.com/inward/record.url?scp=74049114523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049114523&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2009.01625.x

DO - 10.1111/j.1743-6109.2009.01625.x

M3 - Article

C2 - 20092449

AN - SCOPUS:74049114523

VL - 7

SP - 476

EP - 500

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 1 PART 2

ER -